ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLSD Clearside Biomedical Inc

1.31
0.05 (3.97%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 154,219
Bid Price 1.31
Ask Price 1.37
News -
Day High 1.38

Low
0.650101

52 Week Range

High
2.12

Day Low 1.27
Share Name Share Symbol Market Stock Type
Clearside Biomedical Inc CLSD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 3.97% 1.31 18:56:08
Open Price Low Price High Price Close Price Previous Close
1.27 1.27 1.38 1.34 1.26
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
671 154,219 US$ 1.31 US$ 202,723 - 0.650101 - 2.12
Last Trade Type Quantity Price Currency
18:56:07 6 US$ 1.3099 USD

Clearside Biomedical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
99.38M 74.72M - 8.23M -32.49M -0.43 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Clearside Biomedical News

Date Time Source News Article
4/16/202406:05GlobeNewswire Inc.Clearside Biomedical Appoints Seasoned Biotechnology..
4/02/202406:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the..
3/18/202406:05GlobeNewswire Inc.Clearside Biomedical Appoints Victor Chong, M.D., MBA as..
3/12/202415:05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year..
2/29/202406:05GlobeNewswire Inc.Clearside Biomedical to Report Fourth Quarter and Full Year..
2/08/202416:05Edgar (US Regulatory)Form 8-K - Current report
2/08/202415:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/07/202407:00GlobeNewswire Inc.Clearside Biomedical Announces Pricing of $15 Million..
2/01/202415:01Edgar (US Regulatory)Form 8-K - Current report
1/19/202417:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/19/202414:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/28/202315:10Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CLSD Message Board. Create One! See More Posts on CLSD Message Board See More Message Board Posts

Historical CLSD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.331.481.251.35218,785-0.02-1.50%
1 Month1.521.611.101.33280,627-0.21-13.82%
3 Months1.342.121.101.55387,955-0.03-2.24%
6 Months0.732.120.6501011.39285,3740.5879.45%
1 Year1.062.120.6501011.30198,6360.2523.58%
3 Years2.977.730.6501013.42558,886-1.66-55.89%
5 Years1.237.730.562.84584,3220.086.50%

Clearside Biomedical Description

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.

Your Recent History

Delayed Upgrade Clock